title: Drooling.
abstract: BACKGROUND
  Drooling is the overflowing of saliva from the mouth. It is mainly due to neurological disturbance and less frequently to hypersalivation. Drooling can lead to functional and clinical consequences for patients, families, and caregivers. The aim of this review is to emphasize the clinical aspects of the assessing and management of drooling.
  
  
  METHODS
  All papers and clinical reviews of drooling in the electronic data bases (Medline, PubMed, Embase and the Cochrane Library) for the past 40 years in any languages have been evaluated.
  
  
  RESULTS
  The severity of drooling and the effects on the quality of life of the patient and family, help to establish a prognosis and to decide the therapeutic regimen. Treatment options range from conservative therapy to medication, radiation, or surgery, and often a combination is needed.
  
  
  CONCLUSIONS
  Chronic drooling remains a problem that can be difficult to manage. Despite the acceptable results obtained with most of the treatments, none is free of undesirable effects.
authors.affiliation: Eastman Dental Institute, University College London, London, UK.
authors.forename: Crispian
authors.initials: C
authors.lastname: Scully
authors.forename: Jacobo
authors.initials: J
authors.lastname: Limeres
authors.forename: Michael
authors.initials: M
authors.lastname: Gleeson
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Tomás
authors.forename: Pedro
authors.initials: P
authors.lastname: Diz
mesh_terms: D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D009422:Nervous System Diseases / Q000150:complications; D009465:Neuromuscular Agents / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D012469:Salivary Glands / Q000601:surgery; D012798:Sialorrhea / Q000209:etiology / Q000628:therapy
chemical_list: D018727:Muscarinic Antagonists; D009465:Neuromuscular Agents